Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 10 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
110 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
PREMIUM PHARMA RETAIL from Sint-Jans-Molenbeek, company number BE0833748256, closed financial year 2025 with a result of € -12,410 after tax. For that financial year PREMIUM PHARMA RETAIL recorded a gross margin of € -2,595 and equity of € -167,382. Compared with financial year 2024, the result moved from € -24,385 to € -12,410. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2026.
€ -167,382
▼ € 12,410 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -12,410
▲ 49 % less loss than in 2024
Profit after tax over the fiscal year.
€ 2,767
▲ 50% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -185,982.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
€ 35,726
▲ 9% vs 2024
Loans from banks and other lenders, long and short.
€ 35,085
▲ 22% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 6,541
▲ 125% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -14,682 | € -19,391 | € -12,156 | € -2,595 | ▲ € 9,561 |
| Profit after taxes | € -22,888 | € -29,502 | € -24,385 | € -12,410 | ▲ € 11,975 |
| Equity | € -101,085 | € -130,587 | € -154,972 | € -167,382 | ▼ € 12,410 |
| Total debts | € 148,028 | € 173,406 | € 191,971 | € 201,597 | ▲ 5% |
| Cash | - | - | € 1,849 | € 2,767 | ▲ 50% |
| Retained profit | € -119,685 | € -149,187 | € -173,572 | € -185,982 | ▼ € 12,410 |
| Bank debt | € 19,015 | € 30,392 | € 32,702 | € 35,726 | ▲ 9% |
| Balance sheet total | € 46,942 | € 42,819 | € 36,999 | € 34,216 | ▼ 8% |
Key figures of PREMIUM PHARMA RETAIL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PREMIUM PHARMA RETAIL?
What happened at PREMIUM PHARMA RETAIL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 12,410. filed late Source: NBB ↗
- New establishment in Zaventem. KBO
- Olivier Lebbink became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 22,888 loss in 2022 to € 12,410 loss in 2025.
Management
Behind PREMIUM PHARMA RETAIL is Olivier Lebbink. Olivier Lebbink is also behind PREMIUM CONSULTING & MANAGEMENT and PREMIUM PHARMA.
Directors
According to the 2025 annual accounts
since 2017
Establishments
Establishment units
Physical locations of this company
Kolomstraat 1A
1080 Sint-Jans-Molenbeek
Excelsiorlaan 61
1930 Zaventem
Active since 1 September 2019
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 110 companies are registered at this address.
All companies at this address →MGL BATIMENT
€ -23,007 gross margin · 2025
CITY PROMOTION
€ -2,200 gross margin · 2025
GREENHILL
€ -7,520 gross margin · 2024
ZOLFGAR
€ 86,334 revenue · 2025
IMMOFUTUR
€ -7,389 gross margin · 2025
+105 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0833.748.256
- VAT number
- BE 0833.748.256
- Registered office
- Kolomstraat 1A, 1080 Sint-Jans-Molenbeek
- Names & denominations
- PREMIUM PHARMA RETAIL · P.P.R OU PPR
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 February 2011
- Peppol
- Active · Active since 17 Jul 2024
- Activities · NACE
Vervaardiging van farmaceutische grondstoffen
Groothandel in farmaceutische en medische artikelen
Vervaardiging van geneesmiddelen